INSIGHTS ON DRUG DEVELOPMENT
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
-
Ultra-Low Cross-Linked Microgel Purification
ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.
-
Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety
Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.
-
Why Biopharma Breakthroughs Aren't Moving The Market
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
-
Cross-Site Work Within Cambrex's Network7/24/2026
Matthew Zart, Group Leader of Analytical Development, on what happens when a method arrives from another site — inheriting Phase II work from High Point and getting it commercial-ready for the QC lab.
-
Nanomedicine Modalities Find Path To Clinic Through Analytics5/16/2025
Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
Eliminate Risk From Your Viral Vector Tech Transfers12/5/2025
Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.
-
Safety Of Injectables: Ensuring Purity Via Endotoxin Testing7/28/2026
Advance pharmaceutical quality and sustainability by adopting recombinant factor C testing for reliable, animal-free endotoxin detection.
-
3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems3/10/2025
Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.
DRUG DEVELOPMENT SOLUTIONS
-
Integrated lab services deliver method development, validation, and testing across modalities, supporting quality, compliance, and formulation progress from early development to commercialization.
-
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
-
Malvern 2000 Laser Diffraction Particle Size Analyzer with (1) Malvern Model Scirocco 2000, Dry Power Tray Sampler, and (1) Malvern Model Hydro 2000S, Liquid Test Module.
-
Next-generation fluorescent imaging solution for the assurance of monoclonality and automated confluence across diverse cell types
Demonstrating that cell lines are monoclonal – or that a gene was edited as expected – can be a time-consuming and highly-subjective process when relying on conventional technologies. The CloneSelect® Imager and CloneSelect® Imager FL are a high-throughput automated solutions for imaging and analyzing mammalian cells. Tracking the formation of a colony from a single cell is effortless as barcoded plates are tracked over time. Automated acquisition and analysis provides accurate, objective, and consistent results.
-
MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.